Development of a potent peptide inhibitor of estrogen receptor α-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of a potent peptide inhibitor of estrogen receptor α

Published:2018-07 Issue:7 Volume:29 Page:1160-1162
ISSN:1001-8417
Container-title:Chinese Chemical Letters
language:en
Short-container-title:Chinese Chemical Letters

Author:

Qin Xuan,Zhao Hui,Jiang Yanhong,Yin Feng,Tian Yuan,Xie Mingsheng,Ye Xiyang,Xu Naihan,Li Zigang

Funder

National Natural Science Foundation of China

MOST

Shenzhen Science and Technology Innovation Committee

Publisher

Elsevier BV

Subject

General Chemistry

Reference27 articles.

1. Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

2. The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancer

3. Impaired p53 function leads to centrosome amplification, acquired ERα phenotypic heterogeneity and distant metastases in breast cancer MCF-7 xenografts

4. Akt1 and Akt2 Play Distinct Roles in the Initiation and Metastatic Phases of Mammary Tumor Progression

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enzyme-modulate conformational changes in amphiphile peptide for selectively cell delivery;Chinese Chemical Letters;2024-12

2. Material-specific binding peptides empower sustainable innovations in plant health, biocatalysis, medicine and microplastic quantification;Chemical Society Reviews;2024

3. Designing Fluorescent Nuclear Permeable Peptidomimetics to Target Proliferating Cell Nuclear Antigen;Journal of Medicinal Chemistry;2023-07-25

4. Diversity-Oriented Synthesis of ERα Modulators via Mitsunobu Macrocyclization;Organic Letters;2022-05-12

5. Potent Inhibition of HIF1α and p300 Interaction by a Constrained Peptide Derived from CITED2;Journal of Medicinal Chemistry;2021-09-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3